Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Triple hormone receptor agonist retatrutide for metabolic... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
0
Authors
Arun Sanyal
11 more
Arun Sanyal
•
Kieren Mather
9 more
•
Mark Hartman
Published
June 10, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Medicine
Topics
Biology
Bioinformatics
Medicine
Epidemiology
Internal Medicine
Show all topics
DOI
10.1038/s41591-024-03018-2
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Medicine
Topics
Biology
Bioinformatics
Medicine
Epidemiology
Internal Medicine
Show all topics
DOI
10.1038/s41591-024-03018-2
License
CC-BY
Other Formats
PDF
